In vivo post-translational modification of chemokines by DPP4 exerts an inhibition on the migration of T cell to tumors and DPP4 inhibition might therefore be a useful adjuvant treatment for immunotherapy in cancer patients [39]. This evidence concerns the gene DPP4 and cancer.